New York State Common Retirement Fund Fate Therapeutics Inc Transaction History

New York State Common Retirement Fund

  • $73.9 Billion
  • Q3 2024

A detailed history of New York State Common Retirement Fund transactions in Fate Therapeutics Inc stock. As of the latest transaction made, New York State Common Retirement Fund holds 28,015 shares of FATE stock, worth $75,080. This represents 0.0% of its overall portfolio holdings.

Number of Shares
28,015
Previous 28,015 -0.0%
Holding current value
$75,080
Previous $92,000 6.52%
% of portfolio
0.0%
Previous 0.0%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 31, 2024
BUY
$3.26 - $7.08 $65 - $141
20 Added 0.07%
28,015 $92,000
Q1 2024

May 07, 2024
SELL
$3.54 - $8.35 $106 - $250
-30 Reduced 0.11%
27,995 $205,000
Q4 2023

Feb 01, 2024
SELL
$1.65 - $3.94 $277 - $661
-168 Reduced 0.6%
28,025 $105,000
Q3 2023

Nov 07, 2023
BUY
$2.02 - $5.04 $577 - $1,441
286 Added 1.02%
28,193 $60,000
Q2 2023

Aug 07, 2023
SELL
$4.76 - $6.59 $361 - $500
-76 Reduced 0.27%
27,907 $133,000
Q1 2023

May 02, 2023
SELL
$4.24 - $11.12 $182,086 - $477,548
-42,945 Reduced 60.55%
27,983 $160,000
Q4 2022

Jan 30, 2023
SELL
$9.86 - $23.83 $44,034 - $106,424
-4,466 Reduced 5.92%
70,928 $716,000
Q3 2022

Nov 08, 2022
BUY
$21.04 - $36.06 $136,465 - $233,885
6,486 Added 9.41%
75,394 $1.69 Million
Q2 2022

Aug 04, 2022
BUY
$17.78 - $42.39 $11,805 - $28,146
664 Added 0.97%
68,908 $1.71 Million
Q1 2022

May 05, 2022
BUY
$29.67 - $60.28 $175,349 - $356,254
5,910 Added 9.48%
68,244 $2.65 Million
Q4 2021

Feb 02, 2022
BUY
$47.84 - $64.34 $209,826 - $282,195
4,386 Added 7.57%
62,334 $3.65 Million
Q3 2021

Nov 02, 2021
SELL
$59.27 - $95.73 $1.35 Million - $2.18 Million
-22,819 Reduced 28.25%
57,948 $3.44 Million
Q2 2021

Aug 02, 2021
BUY
$67.25 - $92.52 $492,404 - $677,431
7,322 Added 9.97%
80,767 $7.01 Million
Q1 2021

May 11, 2021
BUY
$72.16 - $117.4 $638,255 - $1.04 Million
8,845 Added 13.69%
73,445 $6.06 Million
Q4 2020

Feb 08, 2021
BUY
$38.09 - $100.95 $129,506 - $343,230
3,400 Added 5.56%
64,600 $5.87 Million
Q3 2020

Nov 05, 2020
BUY
$30.41 - $40.5 $112,517 - $149,850
3,700 Added 6.43%
61,200 $2.45 Million
Q2 2020

Aug 07, 2020
BUY
$20.21 - $35.23 $58,609 - $102,166
2,900 Added 5.31%
57,500 $1.97 Million
Q4 2019

Feb 05, 2020
BUY
$13.39 - $20.73 $13,390 - $20,730
1,000 Added 1.87%
54,600 $1.07 Million
Q2 2019

Aug 09, 2019
SELL
$15.61 - $20.44 $603,950 - $790,823
-38,690 Reduced 41.92%
53,600 $1.09 Million
Q1 2019

May 08, 2019
BUY
$13.15 - $18.71 $524,553 - $746,341
39,890 Added 76.13%
92,290 $1.62 Million
Q2 2018

Aug 10, 2018
BUY
$9.16 - $13.48 $109,004 - $160,412
11,900 Added 29.38%
52,400 $594,000
Q2 2017

Aug 11, 2017
BUY
N/A
40,500
40,500 $131,000

Others Institutions Holding FATE

# of Institutions
175
Shares Held
115M
Call Options Held
53.7K
Put Options Held
9K
View Full List

About FATE THERAPEUTICS INC

FATE Quotes by TradingView
  • Ticker FATE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 97,000,304
  • Market Cap $260M
  • Description
  • Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell...
More about FATE
Track This Portfolio

Track New York State Common Retirement Fund Portfolio

Follow New York State Common Retirement Fund and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on New York State Common Retirement Fund with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email